University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Prograf-Advagraf Cross Over Conversion Study

Phase 3

Completed

Conditions: Kidney-Pancreas Transplantation

Interventions: Drug: Tacrolimus

First Posted Date: 2013-02-22

Last Posted Date: 2014-09-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 13

Registration Number: NCT01797341

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Comparing Endoglide to Endoserter for DSAEK Graft Insertion

Not Applicable

Conditions: Fuch's Endothelial Dystrophy
Bullous Keratopathy, Unspecified Eye

Interventions: Device: Endosaver
Device: Tan Endoglide

First Posted Date: 2013-02-13

Last Posted Date: 2013-02-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 42

Registration Number: NCT01791075

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Spinal Morphine for Patients With Obstructive Sleep Apnea

Not Applicable

Suspended

Conditions: Obstructive Sleep Apnea

Interventions: Drug: No Intrathecal Morphine
Drug: Intrathecal Morphine

First Posted Date: 2013-02-13

Last Posted Date: 2019-03-19

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 40

Registration Number: NCT01790971

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Adductor Canal Block In Anterior Cruciate Ligament (ACL) Repair

Not Applicable

Completed

Conditions: Neuromuscular Block

Interventions: Procedure: Adductor Canal Block
Procedure: Femoral Nerve Block

First Posted Date: 2013-02-13

Last Posted Date: 2015-03-04

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT01791036

Locations: 🇨🇦
Women's College Hospital, Toronto, Ontario, Canada

Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)

Not Applicable

Recruiting

Conditions: Lung Cancer

Interventions: Procedure: EBUS-TBNA

First Posted Date: 2013-02-08

Last Posted Date: 2024-12-04

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 150

Registration Number: NCT01786590

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

A Study of Pancreatic Cancer in Xenografts From Liver Metastases

Completed

Conditions: Tumor Tissue Biopsy
Liver Metastases
Blood Samples
Pancreatic Cancer

First Posted Date: 2013-01-24

Last Posted Date: 2023-01-10

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 31

Registration Number: NCT01774643

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy

Not Applicable

Terminated

Conditions: Renal Cell Carcinoma

Interventions: Device: CellAegis' autoRIC™ Device

First Posted Date: 2013-01-18

Last Posted Date: 2015-12-10

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 21

Registration Number: NCT01771003

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases

Phase 2

Completed

Conditions: Solid Tumors With Oligometastatic Spread

First Posted Date: 2013-01-07

Last Posted Date: 2023-04-07

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 138

Registration Number: NCT01761929

Locations: 🇨🇦
University Health Network, Princess Margaret Cancer Center, Toronto, Ontario, Canada

The Effect of Intravitreal Ozurdex on DME After Cataract Surgery

Phase 3

Completed

Conditions: Diabetic Macular Edema

Interventions: Drug: dexamethasone intravitreal implant (OZURDEX)

First Posted Date: 2012-12-12

Last Posted Date: 2015-12-02

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 24

Registration Number: NCT01748487

Locations: 🇨🇦
UHN, Toronto Western Hospital, Toronto, Ontario, Canada

Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Pantoprazole

First Posted Date: 2012-12-12

Last Posted Date: 2021-03-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 21

Registration Number: NCT01748500

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy